Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Geoffrey M Dusheiko & Michael Graham Jacobs. (2009) Perspectives on the management of chronic hepatitis B and C. Expert Review of Anti-infective Therapy 7:3, pages 243-247.
Read now
Read now
Articles from other publishers (15)
Zeyu Zhao, Meijie Chu, Yichao Guo, Shiting Yang, Guzainuer Abudurusuli, Roger Frutos & Tianmu Chen. (2022) Feasibility of Hepatitis C Elimination in China: From Epidemiology, Natural History, and Intervention Perspectives. Frontiers in Microbiology 13.
Crossref
Crossref
Zeynep Altın, Gülden Diniz, Ayfer Çolak, Betül Koyuncu, Serhat Özer, Fatih Aslan & Belkıs Ünsal. (2019) Influence of pegylated interferon and ribavirin on insulin resistance and metabolic factors in chronic hepatitis C. Turkish Journal of Biochemistry 44:2, pages 170-176.
Crossref
Crossref
Narayana Murthy Ganta, Gangaraju Gedda, Bethi Rathnakar, Mavurapu Satyanarayana, Bhaskar Yamajala, Mohamed Jawed Ahsan, Surender Singh Jadav & Tuniki Balaraju. (2019) A review on HCV inhibitors: Significance of non-structural polyproteins. European Journal of Medicinal Chemistry 164, pages 576-601.
Crossref
Crossref
Asres Bedaso, Bereket Duko & Remla Fedlu. (2018) Knowledge on HBV vaccine and vaccination status among health care workers of Hawassa University Comprehensive Specialized Hospital, Hawassa, southern Ethiopia: a cross sectional study. BMC Research Notes 11:1.
Crossref
Crossref
Muhammad Salabat Khan. (2018) Appraisal of circulating biochemical markers and antioxidative activity in interferon intolerant HCV patients. MOJ Cell Science & Report 5:3.
Crossref
Crossref
João Renato Rebello Pinho, Fernanda de Mello Malta & Michele Soares Gomes-Gouvêa. (2017) Hepatitis B, C, and Delta—Updates in Screening and Infection Prevention Opportunities for Eradication. Current Treatment Options in Infectious Diseases 9:1, pages 18-33.
Crossref
Crossref
Fawad Karim, Abu Nasar, Ibrar Alam, Iftikhar Alam, Said Hassan, Rahmat Gul, Sana Ullah & Muhammad Rizwan. (2016) Incidence of Active HCV infection amongst Blood Donors of Mardan District, Pakistan. Asian Pacific Journal of Cancer Prevention 17:1, pages 235-238.
Crossref
Crossref
Faisal Nouroz, Sidra Shaheen, Ghulam Mujtaba & Shumaila Noreen. (2015) An overview on hepatitis C virus genotypes and its control. Egyptian Journal of Medical Human Genetics 16:4, pages 291-298.
Crossref
Crossref
Muhammad Waqar, Asad Ullah Khan, Amjad Ali, Muhammad Wasim, Muhammad Idrees, Zobia Ismail, Agha Asad Noor, Noorul Akbar, Shaista Bano, Muhammad Arif Khan & Rahim Ullah Khan. (2014) Prevalence and Molecular Determination of Hepatitis C Infection in Khyber Pakhtunkhwa, Pakistan. Archives of Clinical Infectious Diseases 9:3.
Crossref
Crossref
Jong-Hwan Lee, Hyuk Seong Seo, Jong Am Song, Koo Chul Kwon, Eun Jung Lee, Ho Jin Kim, Eun Bong Lee, Young Joo Cha & Jeewon Lee. (2013) Proteinticle Engineering for Accurate 3D Diagnosis. ACS Nano 7:12, pages 10879-10886.
Crossref
Crossref
Weida Tong, Qiang Shi, William Salminen, Minjun Chen, Hong Fang, Ayako Suzuki & Donna L. Mendrick. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
Jin Yang, Mei-xin Fang, Jie Li, Guo-qiang Lou, Hang-jun Lu & Nan-ping Wu. (2011) Detection of hepatitis C virus by an improved loop-mediated isothermal amplification assay. Archives of Virology 156:8, pages 1387-1396.
Crossref
Crossref
Arne H. Graff & Laurie D. Frasier. 2011. Child Abuse and Neglect. Child Abuse and Neglect
179
185
.
Yalena Amador-CañizaresSantiago Dueñas-Carrera. (2010) Early Interferon-Based Treatment After Detection of Persistent Hepatitis C Virus Infection: A Critical Decision. Journal of Interferon & Cytokine Research 30:11, pages 817-824.
Crossref
Crossref
Francine Papaiordanou, Marcelo Augusto Fontenelle Ribeiro-Junior & William Abrão Saad. (2009) Prevenção do carcinoma hepatocelular. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 22:2, pages 115-119.
Crossref
Crossref